PPID (Equine Cushing's Syndrome)
Dysfunction of the pituitary gland (pars intermedia) with hormone dysregulation, mainly in older horses. Raises the laminitis risk, among others.
Veterinary care required
This condition belongs in veterinary diagnosis and treatment. Compounds are at most supportive.
Priority · vet & management
PPID belongs in veterinary diagnostics (ACTH) and drug therapy (pergolide — a medicine). Compounds are strictly adjunctive.
Possible causes
- · age-related degeneration of dopaminergic neurons (pars intermedia)
- · progressive hormone dysregulation (including ACTH rise)
- · mainly older horses affected
- · secondarily promotes insulin dysregulation and laminitis
Supportive compounds · supplementary feed, not medication
Chasteberry
AMGFEI freediscussed as adjuvant — no substitute for pergolide, evidence limited; hormonally active, check FEI/rule status before competition
Compound profile →Vitamin C
AMGFEI freeantioxidant in seniors/with increased demand
Compound profile →Milk thistle
AMGFEI freeliver support in senior metabolism
Compound profile →Prevention
PPID cannot be prevented; regular senior check-ups and ACTH tests do, however, enable early veterinary control and laminitis prevention.
Equiterna's take
Equiterna manages PPID strictly vet-centred: diagnostics and pergolide therapy are central, while compounds only accompany the senior metabolism.
Usage note
This content is for information and education. It does not replace veterinary diagnosis or treatment. If your horse shows signs of illness, consult a veterinarian.
Equiterna is an intermediary platform for equine knowledge, marketplace and tools — not a veterinary-medicines dealer, veterinary practice or pharmacy. Compound information is study-attributed and free of healing claims. Legal framework: Regulation (EU) 2019/6 / TAMG (DE/AT), Feed Regulation (EC) 767/2009, FEI Prohibited Substances List, HWG.